APA (7th ed.) Citation

J, S., EM, S., C, A., F, A., L, P., G, Z., . . . M, D. (2020). Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19? Respiratory physiology & neurobiology, 279, 103476. https://doi.org/10.1016/j.resp.2020.103476

Chicago Style (17th ed.) Citation

J, Soliz, et al. "Coping with Hypoxemia: Could Erythropoietin (EPO) Be an Adjuvant Treatment of COVID-19?" Respiratory Physiology & Neurobiology 279 (2020): 103476. https://doi.org/10.1016/j.resp.2020.103476.

MLA (9th ed.) Citation

J, Soliz, et al. "Coping with Hypoxemia: Could Erythropoietin (EPO) Be an Adjuvant Treatment of COVID-19?" Respiratory Physiology & Neurobiology, vol. 279, 2020, p. 103476, https://doi.org/10.1016/j.resp.2020.103476.